BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19808545)

  • 41. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
    Padilla A; Govezensky T; Possani LD; Larralde C
    Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
    Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
    Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand.
    Liu Z; Lerman LO; Tang H; Barber C; Wan L; Hui MM; Furenlid LR; Woolfenden JM
    Nucl Med Biol; 2014; 41(10):785-92. PubMed ID: 25195016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
    Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
    Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment effect with anti-RAGE F(ab')2 antibody improves hind limb angiogenesis and blood flow in Type 1 diabetic mice with left femoral artery ligation.
    Tekabe Y; Anthony T; Li Q; Ray R; Rai V; Zhang G; Schmidt AM; Johnson LL
    Vasc Med; 2015 Jun; 20(3):212-8. PubMed ID: 25808570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse.
    Ueno H; Koyama H; Shoji T; Monden M; Fukumoto S; Tanaka S; Otsuka Y; Mima Y; Morioka T; Mori K; Shioi A; Yamamoto H; Inaba M; Nishizawa Y
    Atherosclerosis; 2010 Aug; 211(2):431-6. PubMed ID: 20435311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers.
    Khaw BA; Tekabe Y; Johnson LL
    J Nucl Med; 2006 May; 47(5):868-76. PubMed ID: 16644758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque.
    Anderson DR; Tsutsui JM; Xie F; Radio SJ; Porter TR
    Cardiovasc Res; 2007 Feb; 73(3):597-606. PubMed ID: 17196951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-/- mice: a pilot study.
    Alsaid H; De Souza G; Bourdillon MC; Chaubet F; Sulaiman A; Desbleds-Mansard C; Chaabane L; Zahir C; Lancelot E; Rousseaux O; Corot C; Douek P; Briguet A; Letourneur D; Canet-Soulas E
    Invest Radiol; 2009 Mar; 44(3):151-8. PubMed ID: 19169144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of monoclonal antibodies against different epitopes on extracellular domain of human receptor for advanced glycation end product.
    Zhu P; Tang L; Zhao SC; Lu X; Hou FF; Fu N
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):129-32. PubMed ID: 14965808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock.
    Raman KG; Sappington PL; Yang R; Levy RM; Prince JM; Liu S; Watkins SK; Schmidt AM; Billiar TR; Fink MP
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G556-65. PubMed ID: 16751175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noninvasive Evaluation of CD20 Expression Using
    Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
    J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoglobulin G (IgG)-Based Imaging Probe Accumulates in M1 Macrophage-Infiltrated Atherosclerotic Plaques Independent of IgG Target Molecule Expression.
    Shimizu Y; Hanzawa H; Zhao Y; Fukura S; Nishijima KI; Sakamoto T; Zhao S; Tamaki N; Ogawa M; Kuge Y
    Mol Imaging Biol; 2017 Aug; 19(4):531-539. PubMed ID: 27981470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. F(ab')
    Li Y; Lu Z; Huang Y; Lopes-Virella MF; Virella G
    Clin Immunol; 2016 Dec; 173():50-56. PubMed ID: 27455858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging.
    Salouti M; Babaei MH; Rajabi H; Foroutan H; Rasaee MJ; Rajabi AB; Mohammadnejad J; Shafiee M; Mazidi M; Daha FJ
    Ann Nucl Med; 2011 Feb; 25(2):87-92. PubMed ID: 21061190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.